Machine Learning Methods in Drug Discovery
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
The advancements of information technology and related processing techniques have created a fertile base for progress in many scientific fields and industries. In the fields of drug discovery and development, machine learning techniques have been used for the development of novel drug candidates. The methods for designing drug targets and novel drug discovery now routinely combine machine learning and deep learning algorithms to enhance the efficiency, efficacy, and quality of developed outputs. The generation and incorporation of big data, through technologies such as high-throughput screening and high through-put computational analysis of databases used for both lead and target discovery, has increased the reliability of the machine learning and deep learning incorporated techniques. The use of these virtual screening and encompassing online information has also been highlighted in developing lead synthesis pathways. In this review, machine learning and deep learning algorithms utilized in drug discovery and associated techniques will be discussed. The applications that produce promising results and methods will be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within the artificial intelligence (AI) discipline, ML methods are considered the most promising techniques for working with unstructured data.”
From Machine learning computational tools to assist the performance of systematic reviews: A mapping review. (2022) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
(2014) · Cited by 33,419
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573
Encyclopedia of Machine Learning
(2010) · Springer eBooks · doi:10.1007/978-0-387-30164-8 · Cited by 3,465
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,182
Dobson, C. M. (2004) · Nature · doi:10.1038/nature03192 · Cited by 1,003
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
3D-QSAR in Drug Design - A Review
Verma, J., Khedkar, V., & Coutinho, E. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232260 · Cited by 830
Deep Audio-Visual Speech Recognition
Afouras, T., Chung, J. S., Senior, A., Vinyals, O., & Zisserman, A. (2022) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2018.2889052 · Cited by 801
Protein–Ligand Scoring with Convolutional Neural Networks
Ragoza, M., Hochuli, J., Idrobo, E., Sunseri, J., & Koes, D. R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00740 · Cited by 774
Prediction of Organic Reaction Outcomes Using Machine Learning
Coley, C. W., Barzilay, R., Jaakkola, T. S., Green, W. H., & Jensen, K. F. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00064 · Cited by 751
Model selection and overfitting
Lever, J., Krzywinski, M., & Altman, N. (2016) · Nature Methods · doi:10.1038/nmeth.3968 · Cited by 694
Advancing drug discovery via artificial intelligence
Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.004 · Cited by 654
Sarica, A., Cerasa, A., & Quattrone, A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00329 · Cited by 644
Computational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Maia, E. H. B., Assis, L. C., de Oliveira, T. A., da Silva, A. M., & Taranto, A. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00343 · Cited by 588
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578
Some Effective Techniques for Naive Bayes Text Classification
Kim, S.-B., Han, K.-S., Rim, H.-C., & Myaeng, S. H. (2006) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2006.180 · Cited by 576
Neural‐Symbolic Machine Learning for Retrosynthesis and Reaction Prediction
Segler, M. H. S., & Waller, M. P. (2017) · Chemistry – A European Journal · doi:10.1002/chem.201605499 · Cited by 548
Rifaioglu, A. S., Atas, H., Martin, M. J., Cetin-Atalay, R., Atalay, V., & Doğan, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 529
The cost of drug development: A systematic review
Morgan, S., Grootendorst, P., Lexchin, J., Cunningham, C., & Greyson, D. (2011) · Health Policy · doi:10.1016/j.healthpol.2010.12.002 · Cited by 510
Deep Learning Sensor Fusion for Autonomous Vehicle Perception and Localization: A Review
Fayyad, J., Jaradat, M. A., Gruyer, D., & Najjaran, H. (2020) · Sensors · doi:10.3390/s20154220 · Cited by 498
Drug development in the era of precision medicine
Dugger, S. A., Platt, A., & Goldstein, D. B. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.226 · Cited by 493
Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas
Chang, P., Grinband, J., Weinberg, B. D., Bardis, M., Khy, M., Cadena, G., Su, M.-Y., Cha, S., Filippi, C. G., Bota, D., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5667 · Cited by 472
From Big Data to Precision Medicine
Hulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D. A., & McKinney, E. F. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00034 · Cited by 459
Machine Learning Paradigms for Speech Recognition: An Overview
Deng, L., & Li, X. (2013) · IEEE Transactions on Audio, Speech, and Language Processing · doi:10.1109/tasl.2013.2244083 · Cited by 456
Generative Recurrent Networks for De Novo Drug Design
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 441
Optimizing Chemical Reactions with Deep Reinforcement Learning
Zhou, Z., Li, X., & Zare, R. N. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00492 · Cited by 437
Exploring chemical compound space with quantum-based machine learning
von Lilienfeld, O. A., Müller, K.-R., & Tkatchenko, A. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0189-9 · Cited by 369
Korotcov, A., Tkachenko, V., Russo, D. P., & Ekins, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00578 · Cited by 352
Synthetic organic chemistry driven by artificial intelligence
de Almeida, A. F., Moreira, R., & Rodrigues, T. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0124-0 · Cited by 303
Machine Learning for Drug-Target Interaction Prediction
Chen, R., Liu, X., Jin, S., Lin, J., & Liu, J. (2018) · Molecules · doi:10.3390/molecules23092208 · Cited by 292
Ryu, B., Kim, D. S., DeLuca, A. M., & Alani, R. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000594 · Cited by 289
Big data analytics for personalized medicine
Cirillo, D., & Valencia, A. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.03.004 · Cited by 269
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
Discrete Bayesian Network Classifiers: A Survey
Bielza, C., & Larrañaga, P. (2014) · ACM Computing Surveys · doi:10.1145/2576868 · Cited by 248
How to explore chemical space using algorithms and automation
Gromski, P. S., Henson, A. B., Granda, J. M., & Cronin, L. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-018-0066-y · Cited by 245
A renaissance of neural networks in drug discovery
Baskin, I. I., Winkler, D., & Tetko, I. V. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1201262 · Cited by 235
The Next Era: Deep Learning in Pharmaceutical Research
Ekins, S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2029-7 · Cited by 235
Machine learning applications in drug development
Réda, C., Kaufmann, E., & Delahaye-Duriez, A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.006 · Cited by 228
Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks
Ghasemi, F., Mehridehnavi, A., Pérez-Garrido, A., & Pérez-Sánchez, H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.06.016 · Cited by 224
Reher, R., Kim, H. W., Zhang, C., Mao, H. H., Wang, M., Nothias, L.-F., Caraballo-Rodriguez, A. M., Glukhov, E., Teke, B., Leao, T., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13786 · Cited by 215
Machine learning models for drug–target interactions: current knowledge and future directions
D’Souza, S., Prema, K. V., & Balaji, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.003 · Cited by 206
A Deep Learning Framework for Predicting Response to Therapy in Cancer
Sakellaropoulos, T., Vougas, K., Narang, S., Koinis, F., Kotsinas, A., Polyzos, A., Moss, T. J., Piha-Paul, S., Zhou, H., Kardala, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.017 · Cited by 204
Application of Artificial Intelligence in COVID-19 drug repurposing
Mohanty, S., Harun AI Rashid, M., Mridul, M., Mohanty, C., & Swayamsiddha, S. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.068 · Cited by 204
DPDDI: a deep predictor for drug-drug interactions
Feng, Y.-H., Zhang, S.-W., & Shi, J.-Y. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03724-x · Cited by 196
Target discovery from data mining approaches
Yang, Y., Adelstein, S. J., & Kassis, A. I. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.005 · Cited by 187
Machine Learning Techniques and Drug Design
Gertrudes, J. C., Maltarollo, V. G., Silva, R. A., Oliveira, P. R., Honorio, K. M., & da Silva, A. B. F. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712802884259 · Cited by 182
Automatic selection of molecular descriptors using random forest: Application to drug discovery
Cano, G., García‐Rodríguez, J., García-García, A., Pérez‐Sánchez, H., Benediktsson, J. A., Thapa, A., & Barr, A. (2016) · Expert Systems with Applications · doi:10.1016/j.eswa.2016.12.008 · Cited by 181
Support vector machines for drug discovery
Heikamp, K., & Bajorath, J. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.866943 · Cited by 177
Search Engines that Learn from Implicit Feedback
Joachims, T., & Radlinski, F. (2007) · Computer · doi:10.1109/mc.2007.289 · Cited by 174
Machine learning in computational docking
Khamis, M. A., Gomaa, W. E., & Ahmed, W. (2015) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2015.02.002 · Cited by 172
Changing Trends in Computational Drug Repositioning
Yella, J. K., Yaddanapudi, S., Wang, Y., & Jegga, A. G. (2018) · Pharmaceuticals · doi:10.3390/ph11020057 · Cited by 166
Rathi, P. C., Ludlow, R. F., & Verdonk, M. L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01129 · Cited by 159
Deep Learning in Drug Discovery and Medicine; Scratching the Surface
Dana, D., Gadhiya, S., Surin, L. S., Li, D., Naaz, F., Ali, Q., Paka, L., Yamin, M., Narayan, M., Goldberg, I. D., et al. (2018) · Molecules · doi:10.3390/molecules23092384 · Cited by 149
Feature selection for the naive bayesian classifier using decision trees
Ratanamahatana, C. A., & Gunopulos, D. (2003) · Applied Artificial Intelligence · doi:10.1080/713827175 · Cited by 148
Machine learning-powered antibiotics phenotypic drug discovery
Zoffmann, S., Vercruysse, M., Benmansour, F., Maunz, A., Wolf, L., Marti, R. B., Heckel, T., Ding, H., Truong, H., Prummer, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39387-9 · Cited by 130
Advances with support vector machines for novel drug discovery
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R., & Honório, K. M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1549033 · Cited by 129
Molecular Transformer unifies reaction prediction and retrosynthesis across pharma chemical space
Lee, A. A., Yang, Q., Sresht, V., Bolgar, P., Hou, X., Klug-McLeod, J. L., & Butler, C. R. (2019) · Chemical Communications · doi:10.1039/c9cc05122h · Cited by 128
Ranking Chemical Structures for Drug Discovery: A New Machine Learning Approach
Agarwal, S., Dugar, D., & Sengupta, S. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9003865 · Cited by 126
Nigsch, F., Bender, A., Jenkins, J. L., & Mitchell, J. B. O. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800079x · Cited by 114
Machine Learning in Drug Discovery and Development Part 1: A Primer
Talevi, A., Morales, J. F., Hather, G. J., Podichetty, J. T., Kim, S., Bloomingdale, P., Kim, S., Burton, J. K., Brown, J. D., Winterstein, A. G., et al. (2020) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12491 · Cited by 102
Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift
Usha, T., Shanmugarajan, D., Goyal, A. K., et al. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180101163651 · Cited by 100
Chemical Space Mimicry for Drug Discovery
Yuan, W., Jiang, D., Nambiar, D. K., Liew, L. P., Hay, M. P., Bloomstein, J. D., Lu, P., Turner, B. E., Le, Q., Tibshirani, R. J., et al. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00754 · Cited by 97
Sun, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050180t · Cited by 96
Drug/nondrug classification using Support Vector Machines with various feature selection strategies
Korkmaz, S., Zararsız, G., & Göksülük, D. (2014) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2014.08.009 · Cited by 88
Artificial intelligence and big data facilitated targeted drug discovery
Liu, B., He, H., Luo, H., Zhang, T., & Jiang, J. (2019) · Stroke and Vascular Neurology · doi:10.1136/svn-2019-000290 · Cited by 86
Pang, X., Fu, W., Wang, J., Kang, D., Xu, L., Zhao, Y., Liu, A., & Du, G. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6040149 · Cited by 86
Ng, H. W., Zhang, W., Shu, M., Luo, H., Ge, W., Perkins, R., Tong, W., & Hong, H. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s11-s4 · Cited by 85
Lee, K., Lee, M., & Kim, D. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1960-x · Cited by 85
Ng, H. W., Shu, M., Luo, H., Ye, H., Ge, W., Perkins, R., Tong, W., & Hong, H. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00243 · Cited by 83
Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space
Kowalewski, J., & Ray, A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04639 · Cited by 79
IntegratedMRF: random forest-based framework for integrating prediction from different data types
Rahman, R., Otridge, J., & Pal, R. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw765 · Cited by 78
Mencattini, A., Giuseppe, D. D., Comes, M. C., Casti, P., Corsi, F., Bertani, F. R., Ghibelli, L., Businaro, L., Natale, C. D., Parrini, M. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64246-3 · Cited by 74
Functional random forest with applications in dose-response predictions
Rahman, R., Dhruba, S. R., Ghosh, S., & Pal, R. (2019) · Scientific Reports · doi:10.1038/s41598-018-38231-w · Cited by 72
Computational advances in combating colloidal aggregation in drug discovery
Reker, D., Bernardes, G. J. L., & Rodrigues, T. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0234-9 · Cited by 72
Anin silicoensemble method for lead discovery: decision forest
Hong, H., Tong, W., Xie, Q., Fang, H., & Perkins, R. (2005) · SAR and QSAR in environmental research · doi:10.1080/10659360500203022 · Cited by 71
Hong, H., Fang, H., Xie, Q., Perkins, R., Sheehan, D. M., & Tong, W. (2003) · SAR and QSAR in environmental research · doi:10.1080/10629360310001623962 · Cited by 71
Kernel-based data fusion improves the drug–protein interaction prediction
Wang, Y., Zhang, C., Deng, N.-Y., & Wang, Y. (2011) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2011.10.003 · Cited by 70
Fields, F. R., Freed, S. D., Carothers, K. E., Hamid, M.-N., Hammers, D. E., Ross, J. N., Kalwajtys, V. R., Gonzalez, A. J., Hildreth, A. D., Friedberg, I., et al. (2019) · Drug Development Research · doi:10.1002/ddr.21601 · Cited by 64
Machine learning for target discovery in drug development
Rodrigues, T., & Bernardes, G. J. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.003 · Cited by 62
Identification of HIV-1 Integrase Inhibitors Based on a Four-Point Pharmacophore
Hong, H., Neamati, N., Winslow, H. E., Christensen, J., Orr, A., Pommier, Y. G., & Milne, G. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900602 · Cited by 60
Predictive Activity Profiling of Drugs by Topological-Fragment-Spectra-Based Support Vector Machines
Kawai, K., Fujishima, S., & Takahashi, Y. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7004753 · Cited by 59
Scaling Multidimensional Inference for Structured Gaussian Processes
Gilboa, E., Saatçi, Y., & Cunningham, J. P. (2013) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2013.192 · Cited by 57
Wei, Y., Li, W., Du, T., Hong, Z., & Lin, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143572 · Cited by 44
A new complement naïve Bayesian approach for biomedical data classification
Amare, A., & Chang, Y.-L. (2018) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-018-1160-1 · Cited by 43
Hinselmann, G., Rosenbaum, L., Jahn, A., Fechner, N., Ostermann, C., & Zell, A. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100073w · Cited by 36
Exploring Chemical Space with Machine Learning
Arús‐Pous, J., Awale, M., Probst, D., & Reymond, J. (2019) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2019.1018 · Cited by 36
Changing Trends in Computational Drug RepositioningPreprint
Yella, J., Yaddanapudi, S., Wang, Y., et al. (2018) · Preprints.org · doi:10.20944/preprints201805.0011.v1 · Cited by 26
Applications of Machine Learning in Drug Target Discovery
Gao, D., Chen, Q., Zeng, Y., Jiang, M., & Zhang, Y. (2020) · Current Drug Metabolism · doi:10.2174/1567201817999200728142023 · Cited by 25
Dual ACE and NEP Inhibitors: A Review of the Pharmacological Properties of MDL 100,240
Rossi, G. P. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00105.x · Cited by 22
Error Tolerance of Machine Learning Algorithms across Contemporary Biological Targets
Kaiser, T. M., & Burger, P. B. (2019) · Molecules · doi:10.3390/molecules24112115 · Cited by 18
Identification of the Dual Action Antihypertensive Drugs Using TFS-Based Support Vector Machines
Kawai, K., & Takahashi, Y. (2009) · Chem-Bio Informatics Journal · doi:10.1273/cbij.9.41 · Cited by 18
Wassermann, A. M., Geppert, H., & Bajorath, J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_21 · Cited by 17
Wei, Y., Li, W., Du, T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/605162 · Cited by 5
Cited by
Visan, A. I., & Negut, I. (2024) · Life · doi:10.3390/life14020233 · Cited by 279
Machine learning for perturbational single-cell omics
Ji, Y., Lotfollahi, M., Wolf, F. A., & Theis, F. J. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.016 · Cited by 137
Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Schleinitz, J., Langevin, M., Smail, Y., Wehnert, B., Grimaud, L., & Vuilleumier, R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c05302 · Cited by 88
Cierco Jimenez, R., Lee, T., Rosillo, N., Cordova, R., Cree, I. A., Gonzalez, A., & Indave Ruiz, B. I. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01805-4 · Cited by 85
Metadata
- Authors
- Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S.
- Affiliations
- University of Arkansas at Little Rock (US)
- Arkansas State University (US)
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Wang, Shanzhi
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-11-12
- Volume
- 25
- Issue
- 22
- Pages
- 5277
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7696134
- OpenAlex
- W3099252273
- Cited by
- 460
- References
- 103
- Citations by year
- 2026: 58 · 2025: 93 · 2024: 104 · 2023: 92 · 2022: 84 · 2021: 27
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The Arkansas Department of Education (ADE) (2019SURF)
- Federal TRIO Programs, United States Department of Education (McNair (LP))
- NSF (1946391)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- machine learning in drug discovery, deep learning, drug target identification, virtual screening, lead compound identification, high-throughput screening, big data, drug candidate design
- MeSH terms
- Machine Learning, Deep Learning, Algorithms, Bayes Theorem, Humans, Monte Carlo Method, Software, Reproducibility of Results, Databases, Factual, Computational Biology, Internet, Drug Discovery, Support Vector Machine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.